Does the Immune System Naturally Protect Against Cancer?
暂无分享,去创建一个
[1] T. Oshikiri,et al. CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. , 2003, Cancer research.
[2] A. Hayday,et al. Regulation of cutaneous malignancy by gammadelta T cells. , 2001, Science.
[3] M BURNET,et al. Cancer—A Biological Approach* , 1957, British medical journal.
[4] Axel Hoos,et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. , 2011, The New England journal of medicine.
[5] S. Gasser,et al. Regulation of ligands for the NKG2D activating receptor. , 2013, Annual review of immunology.
[6] R. Hoover,et al. Risk of cancer in renal-transplant recipients. , 1973, Lancet.
[7] L. Lanier,et al. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] L. Notarangelo,et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. , 1997, Journal of immunology.
[9] Ariadni Mavrou,et al. Development of cancer in patients with primary immunodeficiencies. , 2008, Anticancer research.
[10] C. Creaser,et al. Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. , 2001, Blood.
[11] M. Burnet. Cancer—A Biological Approach , 1957, British medical journal.
[12] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[13] J. Peto,et al. PROSPECTIVE STUDY OF CANCER IN PATIENTS WITH HYPOGAMMAGLOBULINAEMIA , 1985, The Lancet.
[14] S. Rosenberg,et al. Identification of a Novel Major Histocompatibility Complex Class II–restricted Tumor Antigen Resulting from a Chromosomal Rearrangement Recognized by CD4+ T Cells , 1999, The Journal of experimental medicine.
[15] R. Schreiber,et al. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice , 1998 .
[16] J. Trapani,et al. A fresh look at tumor immunosurveillance and immunotherapy , 2001, Nature Immunology.
[17] W. Savage,et al. GYNAECOLOGISTS' ATTITUDES TO ABORTION , 1989, The Lancet.
[18] F. Nagengast,et al. Colorectal cancer in patients with X-linked agammaglobulinaemia , 1993, The Lancet.
[19] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[20] J. Trapani,et al. Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ , 2002, The Journal of experimental medicine.
[21] R. Schreiber,et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] S. Rosenberg,et al. Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. , 1999, Science.
[23] T. Spies,et al. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB , 1999 .
[24] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[25] C. Drake,et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. , 2012, The New England journal of medicine.
[26] F. Davi,et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] T. Dønnem,et al. Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.
[28] A. Tutt,et al. Immunological Visibility: Posttranscriptional Regulation of Human NKG2D Ligands by the EGF Receptor Pathway , 2014, Science Translational Medicine.
[29] R. Schreiber,et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.
[30] Xin Wei Wang,et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. , 2006, Cancer cell.
[31] Olivia Keiser,et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. , 2005, Journal of the National Cancer Institute.
[32] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[33] C. Horak,et al. Nivolumab plus ipilimumab in advanced melanoma. , 2013, The New England journal of medicine.
[34] G. Opelz,et al. Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[35] P. Matzinger,et al. Is cancer dangerous to the immune system? , 1996, Seminars in immunology.
[36] George Coukos,et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.
[37] M. Guiguet,et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. , 2009, The Lancet. Oncology.
[38] M. Pfreundschuh,et al. Human neoplasms elicit multiple specific immune responses in the autologous host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[39] David Haussler,et al. Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling , 2011, Proceedings of the National Academy of Sciences.
[40] B. Lippitz,et al. Cytokine patterns in patients with cancer: a systematic review. , 2013, The Lancet. Oncology.
[41] S. Ferrone,et al. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. , 1991, The Journal of clinical investigation.
[42] V. Preedy,et al. Prospective Cohort Study , 2010 .
[43] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.
[44] F. Burnet. The concept of immunological surveillance. , 1970, Progress in experimental tumor research.
[45] N. Hayashi,et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid , 2003, International journal of cancer.
[46] E. Schaftingen,et al. High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival. , 2001, Cancer research.
[47] R. Schreiber,et al. Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.
[48] J. Blay,et al. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors. , 2013, Cancer research.
[49] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[50] C. Sautès-Fridman,et al. The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.
[51] T. Schulz. Cancer and viral infections in immunocompromised individuals , 2009, International journal of cancer.
[52] S. Bauer,et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[53] A. Hayday,et al. Regulation of Cutaneous Malignancy by γδ T Cells , 2001, Science.
[54] J. Trapani,et al. Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma , 2000, The Journal of experimental medicine.
[55] D. Dunn,et al. CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS , 1978, The Lancet.
[56] R. Vaughan,et al. An NKG2D-Mediated Human Lymphoid Stress Surveillance Response with High Interindividual Variation , 2011, Science Translational Medicine.
[57] N. Greenberg,et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. , 2008, Immunity.
[58] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[59] A. Gemma,et al. Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer , 2008, Cancer.
[60] Jennifer Couzin-Frankel,et al. Breakthrough of the year 2013. Cancer immunotherapy. , 2013, Science.
[61] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[62] M. Smyth,et al. NKG2D function protects the host from tumor initiation , 2005, The Journal of experimental medicine.
[63] Boris Pasche,et al. TGF-β: duality of function between tumor prevention and carcinogenesis. , 2014, Journal of the National Cancer Institute.
[64] H Nagura,et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. , 1998, Cancer research.
[65] J. Shabanowitz,et al. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene. , 1998, Cancer research.
[66] B. Mueller,et al. Cancer in children with primary or secondary immunodeficiencies. , 1995, The Journal of pediatrics.
[67] Yuchen Jiao,et al. Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer , 2014, Science.
[68] Richard L. Abbott,et al. A Follow-up Study , 1990 .
[69] L. Feuk,et al. Genome-wide association study of susceptibility loci for cervical cancer. , 2013, Journal of the National Cancer Institute.
[70] Ian O Ellis,et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] T. Karlsen,et al. Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms , 2007, Hepatology.
[72] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[73] A. Diefenbach,et al. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity , 2001, Nature.
[74] J. Cayuela,et al. BCR/ABL Oncogene Directly Controls MHC Class I Chain-Related Molecule A Expression in Chronic Myelogenous Leukemia1 , 2006, The Journal of Immunology.
[75] R. Gatti,et al. Occurrence of malignancy in immunodeficiency diseases: A literature review , 1971, Cancer.
[76] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[77] F. Garrido,et al. Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors , 1999, International journal of cancer.
[78] Yao-Tseng Chen,et al. Characterization of human colon cancer antigens recognized by autologous antibodies , 1998, International journal of cancer.
[79] T. Oshikiri,et al. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma , 2006, British Journal of Cancer.
[80] A Steinle,et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.
[81] L. Thomas. On immunosurveillance in human cancer. , 1982, The Yale journal of biology and medicine.
[82] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[83] Orchard Tj. Letter: Mobile coronary care. , 1974 .
[84] M. R. Oliva,et al. A new beta 2 microglobulin mutation found in a melanoma tumor cell line. , 1999, Tissue antigens.
[85] P. Stern,et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. , 1997, Immunology today.
[86] G. Willimsky,et al. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance , 2005, Nature.
[87] Ming Li,et al. An Immunosurveillance Mechanism Controls Cancer Cell Ploidy , 2012, Science.
[88] S. Davis,et al. Exome sequencing identifies GRIN2A as frequently mutated in melanoma , 2011, Nature Genetics.
[89] S. Cole,et al. A Meta-Analysis of the Incidence of Non-AIDS Cancers in HIV-Infected Individuals , 2009, Journal of acquired immune deficiency syndromes.
[90] Jae Hyun Kim,et al. High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer , 2008, British Journal of Cancer.
[91] R. Schreiber,et al. A critical function for type I interferons in cancer immunoediting , 2005, Nature Immunology.
[92] Eero Pukkala,et al. Cancer risk after renal transplantation in the nordic countries, 1964–1986 , 1995, International journal of cancer.
[93] Eric J. Brown,et al. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor , 2005, Nature.
[94] F. Greco,et al. Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[95] M. Smyth,et al. Immune surveillance of tumors. , 2007, The Journal of clinical investigation.
[96] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[97] R. Palmqvist,et al. High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer , 2007, Clinical Cancer Research.
[98] P. Coulie,et al. A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma. , 2001, Cancer research.
[99] A. Israni,et al. Spectrum of cancer risk among US solid organ transplant recipients. , 2011, JAMA.
[100] G. Opelz,et al. Cytomegalovirus Prophylaxis and Graft Outcome in Solid Organ Transplantation: A Collaborative Transplant Study Report , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[101] K. O'Byrne,et al. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[102] N. Levine. THE BIOLOGICAL APPROACH , 1950 .
[103] S. Gasser,et al. Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands , 2012, The Journal of Immunology.
[104] B. O'Sullivan,et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. , 1996, Transplantation.
[105] S. Crystal,et al. HIV as an independent risk factor for incident lung cancer , 2012, AIDS.
[106] S. Bahram,et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[107] M. Serrano,et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.
[108] G. Edgren,et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008—A Swedish population‐based study , 2013, International journal of cancer.
[109] T. Wheeler,et al. Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. , 2000, Cancer research.
[110] Li Ding,et al. Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.
[111] J. Nesland,et al. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[112] D. Raulet,et al. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry , 2012, The Journal of experimental medicine.
[113] D. Nicol,et al. Non-melanoma skin cancer risk in the Queensland renal transplant population. , 2002 .